Paysign, Inc. - Common Stock (PAYS)
10.84
-1.67 (-13.35%)
NASDAQ · Last Trade: Nov 10th, 10:31 AM EST
News & Press Releases
Paysign (PAYS) Q3 2026 Earnings Call Transcriptfool.com
Patient programs drove margin gains, but a plasma client's departure looms in Q4.
Via The Motley Fool · November 10, 2026
Paysign Q3 Earnings Call Highlightsmarketbeat.com
Paysign (NASDAQ:PAYS) reported record third-quarter revenue, operating income and adjusted EBITDA as growth in its patient affordability business more than offset slower growth in plasma payment processing.
Revenue rose 42.6% from a year earlier to $30.8 million, while net income climbed to $6.7 mi
Via MarketBeat · November 9, 2026
Paysign (NASDAQ:PAYS) Q3 2026 Beat and Stronger Profit Guidance Offset Plasma Customer Exit Concernschartmill.com
Via Chartmill · November 9, 2026
Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8%
Paysign, Inc. (NASDAQ: PAYS), a provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced financial results for the third quarter 2026.
By Paysign, Inc. · Via Business Wire · November 9, 2026
Paysign Inc (NASDAQ:PAYS) Highlights High-Growth Leadership and Momentumchartmill.com
Via Chartmill · November 6, 2026
Paysign (NASDAQ:PAYS) Stands Out for High Growth and Improving Fundamentalschartmill.com
Via Chartmill · October 19, 2026
Paysign (NASDAQ:PAYS) Shows High-Growth Leadership and Strong Momentumchartmill.com
Via Chartmill · October 16, 2026
PaySign (NASDAQ:PAYS) Meets Minervini Trend Template and High-Growth Momentum Screenchartmill.com
Via Chartmill · September 30, 2026
Paysign to Host Third Quarter 2026 Earnings Call
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, will discuss third quarter 2026 earnings at 5:00 p.m. Eastern time on Monday, November 9, 2026.
By Paysign, Inc. · Via Business Wire · October 13, 2026
Paysign (NASDAQ:PAYS) Delivers High Growth and Improving Fundamentalschartmill.com
Via Chartmill · September 26, 2026
Paysign (NASDAQ:PAYS): High-Growth Leadership With Strong Momentumchartmill.com
Via Chartmill · September 23, 2026
Paysign Inc (NASDAQ:PAYS) Accelerates Growth with Soaring Earnings Estimates and Expanding Marginschartmill.com
Via Chartmill · September 5, 2026
Paysign Inc (NASDAQ:PAYS) Shows High-Growth Leadership and Strong Momentumchartmill.com
Via Chartmill · September 1, 2026
Paysign Targets $117M Revenue as Patient-Affordability Business Surgesmarketbeat.com
Paysign (NASDAQ:PAYS) operates in two healthcare-focused businesses: payment services for plasma donors and pharmaceutical patient-affordability programs, Chief Financial Officer Jeff Baker said during a company presentation.
Baker described the company as both a payments and life sciences business
Via MarketBeat · August 28, 2026
Paysign Inc (NASDAQ:PAYS) Shows Accelerating Growth and Improving Fundamentalschartmill.com
Via Chartmill · August 12, 2026
Paysign (NASDAQ:PAYS): High-Growth Leadership and Momentum in Focuschartmill.com
Via Chartmill · August 8, 2026
Paysign (NASDAQ:PAYS) Flashes Minervini-Style Momentum With Strong Uptrend and Accelerating Fundamentalschartmill.com
Via Chartmill · August 6, 2026
Paysign (NASDAQ:PAYS) Soars on Q2 Beat and Raised Full-Year Guidancechartmill.com
Via Chartmill · August 5, 2026
Paysign Inc (NASDAQ:PAYS) Screens as High Growth Leader Under CAN SLIM Methodologychartmill.com
Via Chartmill · July 16, 2026
Paysign, Inc. to Present at the 17th Annual Midwest IDEAS Investor Conference
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the 17th Annual Midwest IDEAS Investor Conference to be held August 26-27, 2026 at the InterContinental in Chicago, Illinois.
By Paysign, Inc. · Via Business Wire · August 18, 2026
Paysign Q2 Earnings Call Highlightsmarketbeat.com
Paysign (NASDAQ:PAYS) reported record second-quarter revenue, net income and adjusted EBITDA for 2026, driven primarily by continued expansion in its Patient Affordability business and improving utilization in its plasma donor compensation operations.
Revenue rose 48.1% from a year earlier to $28.3
Via MarketBeat · August 6, 2026
Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million, Up 48%; Raises Full-Year Outlook
Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive pharma patient affordability offerings, financial technology products and integrated payment processing, today announced financial results for the second quarter 2026.
By Paysign, Inc. · Via Business Wire · August 5, 2026
Paysign to Host Second Quarter 2026 Earnings Call
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, will discuss second quarter 2026 earnings at 5:00 p.m. Eastern time on Wednesday, August 5, 2026.
By Paysign, Inc. · Via Business Wire · July 14, 2026